Last update June 24, 2022
Chloral hydrate is a hypnotic and sedative with properties similar to those of barbiturates. It is used in the treatment of insomnia, as a sedative and as an anesthetic premedication. Oral administration one to three times a day.
It is excreted in breast milk in moderate amount, which could be clinically significant. (Bernstine 1956)
Single doses in nursing mothers did not cause adverse effects in nursing infants. (Bernstine 1956)
A daily dose in a nursing mother caused transient minimal sedation with no long-term adverse effects on the infant. (Lacey 1971)
It has been used as a hypnotic in young infants as sedation for non-painful examinations (CT, EEG, MRI).
Punctual use is compatible with breastfeeding (WHO 2002). Avoid repeated use: it can cause drowsiness.
American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding. (AAP 2001)
It is recommended to check for sedation and adequate feeding in infants. Bed-sharing (co-sleeping) with the baby is not recommended if this drug are used. (ABM 2020 y 2008, UNICEF 2018, 2017, 2014 y 2013, Landa 2012, UNICEF 2006)
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM